Ladenburg, Germany, 12 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...

For older women, menopausal hormone therapy (HT) use is associated with faster regional tau accumulation, according to a ...

DAVID SWARTZ, Director at RadNet RDNT , reported an insider sell on March 12, according to a new SEC filing. What Happened: SWARTZ's decision to sell 25,000 shares of RadNet was revealed in a Form 4 ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

Strange events at the heart of the Milky Way could point toward a new dark suspect that annihilates to influence the chemistry of the cosmos.

FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell ...

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical ...

Positron’s innovative PET/PET-CT technologies, clinical services and practice solutions enables healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes ...